Douglas B. Evans

发表

Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.

L. Ellis, O. Stoeltzing, Wenbiao Liu, 2003, The American journal of pathology.

The Molecular Biology of Pancreatic Cancer

Douglas B. Evans, M. E. Jean, A. Lowy, 2002 .

Cancer-associated stromal fibroblasts promote pancreatic tumor progression.

Douglas B. Evans, R. Hwang, A. Rivera, 2008, Cancer research.

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

Jeffrey E. Lee, K. Hess, Douglas B. Evans, 2001, Annals of Surgical Oncology.

Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation.

Douglas B. Evans, E. Abdalla, R. Wolff, 2002, The oncologist.

The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer.

Douglas B. Evans, R. Wolff, P. Pisters, 2006, Best practice & research. Clinical gastroenterology.

Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study.

Douglas B. Evans, A. A. Aadam, A. Khan, 2012, Gastrointestinal endoscopy.

Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.

R. Jeffrey, Douglas B. Evans, S. Mandel, 2005, Ultrasound quarterly.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Manal M. Hassan, Douglas B. Evans, E. Abdalla, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

Douglas B. Evans, J. Vauthey, C. Charnsangavej, 2001, International journal of radiation oncology, biology, physics.

Diagnosis, staging, and surveillance of pancreatic cancer.

P. Silverman, Douglas B. Evans, C. Charnsangavej, 2003, AJR. American journal of roentgenology.

Adenovirus-mediated wild-typep53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer

Michael Bouvet, Richard J. Bold, David J. McConkey, 1998, Annals of Surgical Oncology.

Central compartment lymph node dissection for differentiated thyroid cancer: review of the literature

Douglas B. Evans, Tracy S. Wang, Victoria Lai, 2014 .

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreaticoduodenectomy with vascular resection: margin status and survival duration

Christopher H. Crane, Eddie K. Abdalla, Jeffrey E. Lee, 2004, Journal of Gastrointestinal Surgery.

Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2007, Annals of surgery.

Tumor‐Node‐Metastasis Staging of Pancreatic Adenocarcinoma

Douglas B. Evans, R. Hwang, M. Katz, 2008, CA: a cancer journal for clinicians.

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2014, Journal of Gastrointestinal Surgery.

Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?

B. Erickson, Douglas B. Evans, Huamin Wang, 2014, The oncologist.

Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2020, Surgery.

Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?

B. Erickson, Douglas B. Evans, S. Tsai, 2017, Journal of Gastrointestinal Surgery.

Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2013, Journal of Gastrointestinal Surgery.

Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.

Douglas B. Evans, M. Hung, W. Xia, 2007, Cancer cell.

A multispecialty approach to the diagnosis and management of pancreatic cancer

Irving Waxman, Kenneth J. Chang, Robert H Hawes, 2000, American Journal of Gastroenterology.

Thyroid cancer in adolescents and young adults

Douglas B. Evans, A. Bleyer, M. Massimino, 2018, Pediatric blood & cancer.

Ten‐year experience in optimizing neoadjuvant therapy for localized pancreatic cancer—Medical college of Wisconsin perspective

Douglas B. Evans, S. Tsai, Erin P. Ward, 2021, Journal of surgical oncology.

The learning curve in pancreatic surgery.

Jeffrey E. Lee, Douglas B. Evans, Huamin Wang, 2007, Surgery.

The learning curve in pancreatic surgery (DOI: 10.1016/j.surg.2006.09.013)

Jeffrey E. Lee, Douglas B. Evans, Huamin Wang, 2007 .

Novel Chemoradiation in Localized Pancreatic Cancer: Clinical Studies

Douglas B. Evans, R. Wolff, P. Pisters, 2006 .

Radiation Dose Considerations in the Palliative Treatment of Locally Advanced Adenocarcinoma of the Pancreas

Douglas B. Evans, R. Wolff, L. Ho, 2005, American journal of clinical oncology.

NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity

Christian Schmidt, James L. Abbruzzese, Douglas B. Evans, 2004, Molecular and Cellular Biology.

Dietary Mutagen Exposure and Risk of Pancreatic Cancer

Rashmi Sinha, James L. Abbruzzese, Manal M. Hassan, 2007, Cancer Epidemiology Biomarkers & Prevention.

Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κB*

Peng Huang, Christian Schmidt, James L. Abbruzzese, 2004, Journal of Biological Chemistry.

A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma

B. Erickson, Douglas B. Evans, Syed A. Ahmad, 2018, Annals of surgery.

Analysis of free-form radiology dictations for completeness and clarity for pancreatic cancer staging

Eric P. Tamm, Patricia S. Fox, Douglas B. Evans, 2015, Abdominal Imaging.

Replaced gastroduodenal artery: Added benefit of the “artery first” approach during pancreaticoduodenectomy—A case report

Douglas B. Evans, S. Tsai, K. Christians, 2016, International journal of surgery case reports.

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models

Douglas B. Evans, Bryon D Johnson, J. Gershan, 2018, BMC Cancer.

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

Douglas B. Evans, J. Abbruzzese, P. Chiao, 1999, Oncogene.

Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer—Is it indicated?

B. Erickson, Douglas B. Evans, S. Tsai, 2016, Journal of surgical oncology.

Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique

Douglas B. Evans, C. Charnsangavej, M. Frazier, 1996, Annals of Surgical Oncology.

Prognostic factors in resectable pancreatic cancer: p53 and Bcl-2

K. Hess, C. Bucana, Douglas B. Evans, 1999, Journal of Gastrointestinal Surgery.

Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer".

Douglas B. Evans, Tracy S. Wang, K. Cheung, 2013, Surgery.

Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients.

Jeffrey E. Lee, B. Fornage, Douglas B. Evans, 2003, American journal of surgery.

Unusual Pancreatic Tumors

Douglas B. Evans, Huamin Wang, E. A. Asare, 2019, Shackelford's Surgery of the Alimentary Tract, 2 Volume Set.

Function of nuclear factor kappaB in pancreatic cancer metastasis.

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Therapeutic Advances in Localized Pancreatic Cancer.

Susan Tsai, Douglas B. Evans, S. Tsai, 2016, JAMA surgery.

Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy

B. Erickson, Douglas B. Evans, S. Tsai, 2020, Frontiers in Oncology.

The Future of Multidisciplinary Care in Pancreatic Cancer

Douglas B. Evans, S. Tsai, 2019, Management of Localized Pancreatic Cancer.

Locally advanced pancreas cancer: Staging and goals of therapy

B. Erickson, Douglas B. Evans, S. Tsai, 2018, Surgery.

Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2020, Annals of surgery.

Stromal Inflammation in Pancreatic Cancer: Mechanisms and Translational Applications

Kathleen A. Boyle, Douglas B. Evans, S. Tsai, 2017 .

Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis

Naveen M. Kulkarni, Douglas B. Evans, S. O'Connor, 2018, Abdominal Radiology.

Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease.

B. Erickson, Douglas B. Evans, S. Tsai, 2016, Journal of oncology practice.

Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

K. Lillemoe, Douglas B. Evans, M. Farnell, 2009, Annals of Surgical Oncology.

Current staging systems for pancreatic cancer.

Douglas B. Evans, S. Tsai, P. Tolat, 2012, Cancer journal.

Arterial resection at the time of pancreatectomy for cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2014, Surgery.

Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer.

B. Erickson, Douglas B. Evans, F. Johnston, 2015, Surgery.

Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy

Douglas B. Evans, S. Tsai, B. George, 2015, Annals of Surgical Oncology.

Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer.

B. Erickson, Douglas B. Evans, F. Johnston, 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.

B. Erickson, Douglas B. Evans, F. Johnston, 2016, Surgery.

Pancreaticoduodenectomy after placement of endobiliary metal stents

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2005, Journal of Gastrointestinal Surgery.

Future chemoradiation strategies in pancreatic cancer.

Douglas B. Evans, R. Wolff, P. Pisters, 2007, Seminars in oncology.

Preoperative (Neoadjuvant) Therapy for Resectable Adenocarcinoma of the Pancreas

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2002 .

Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology

B. Erickson, A. Azmi, Douglas B. Evans, 2021, Cancer and Metastasis Reviews.

Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.

L. Ellis, Douglas B. Evans, J. Trevino, 2005, Cancer research.

Persistent/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role?

Douglas B. Evans, Tracy S. Wang, T. Yen, 2019, The Journal of surgical research.

Novel Multimodality Treatment Sequencing for Extrahepatic (Mid and Distal) Cholangiocarcinoma

Douglas B. Evans, T. Gamblin, S. Tsai, 2013, Annals of Surgical Oncology.

Role of lymph node dissection in primary surgery for thyroid cancer.

Douglas B. Evans, E. Grubbs, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

Carcinoma of the male breast and klinefelter's syndrome: Is there an association?

Douglas B. Evans, R. W. Crichlow, 1987, CA: a cancer journal for clinicians.

A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma.

Douglas B. Evans, A. El‐Naggar, E. A. Barnes, 2004, The Journal of clinical endocrinology and metabolism.

Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.

Jeffrey E. Lee, Douglas B. Evans, S. Sherman, 2002, Surgery.

Cost and Utilization Impact of a Clinical Pathway for Patients Undergoing Pancreaticoduodenectomy

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 2000, Annals of Surgical Oncology.

The recognition and surgical management of heritable lesions of the pancreas.

Douglas B. Evans, J. Fleming, Michael P. Kim, 2009, Surgical oncology clinics of North America.

Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma.

Douglas B. Evans, Daniel J. Rowan, S. Tsai, 2020, Annals of diagnostic pathology.

Neutrophil‐lymphocyte and platelet‐lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma

J. Sicklick, T. Pawlik, Douglas B. Evans, 2015, Journal of surgical oncology.

Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.

Wei Zhang, K. Hess, Douglas B. Evans, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Staging and Therapeutic Approaches for Patients with Localized, Potentially Curable Pancreatic Adenocarcinoma

Douglas B. Evans, R. Wolff, P. Pisters, 2005 .

Disparities in access to care and outcomes in patients with adrenocortical carcinoma.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2017, The Journal of surgical research.

Thyroid cancer in young adults.

Douglas B. Evans, S. Waguespack, W. Huh, 2009, Seminars in oncology.

Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-κb signaling pathway with the anti-epidermal growth factor antibody IMC-C225

Douglas B. Evans, P. Chiao, Z. Fan, 2003, Journal of Gastrointestinal Surgery.

Novel applications of endo GIA linear staplers during pancreaticoduodenectomy and total pancreatectomy.

Douglas B. Evans, P. Pisters, 2003, American journal of surgery.

The role of intraoperative radiotherapy in pancreatic cancer.

Douglas B. Evans, A. Beddar, C. Crane, 2003, Surgical oncology clinics of North America.

Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.

C. Bucana, Douglas B. Evans, R. Hwang, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice.

C. Bucana, Douglas B. Evans, R. Hwang, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Preoperative chemoradiation for resectable and locailv, advanced adenocarcinoma of the pancreas

Douglas B. Evans, 2001, Journal of Gastrointestinal Surgery.

Chemoradiation for Localized Pancreatic Cancer: Another Perspective

Douglas B. Evans, J. Abbruzzese, 1999, Annals of Surgical Oncology.

Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis

Jeffrey E. Lee, Douglas B. Evans, S. Leach, 1999, Journal of Gastrointestinal Surgery.

Standard Forms of Pancreatic Resection

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 1998 .

Resection of the Superior Mesenteric-Portal Vein Confluence During Pancreaticoduodenectomy

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 1997 .

Post‐therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2012, Cancer.

Neoadjuvant Chemoradiation for Operable Pancreatic Cancer: The Importance of Local Disease Control

B. Erickson, Douglas B. Evans, S. Tsai, 2018 .

Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone

S. Curley, Douglas B. Evans, I. Wistuba, 2008, Annals of Surgical Oncology.

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated

Douglas B. Evans, J. Vauthey, A. Baschnagel, 2006, Radiation oncology.

Concurrent endocrine and other surgical procedures: an institutional experience.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2017, The Journal of surgical research.

Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.

Douglas B. Evans, B. Campbell, Tracy S. Wang, 2018, Thyroid : official journal of the American Thyroid Association.

Analysis of an institutional protocol for thyroid lobectomy: Utility of routine intraoperative frozen section and expedited (overnight) pathology.

Douglas B. Evans, F. Quiroz, Tracy S. Wang, 2016, Surgery.

Institutional experience with lateral neck dissections for thyroid cancer.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2015, Surgery.

The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer.

Douglas B. Evans, F. Quiroz, Tracy S. Wang, 2013, Surgery.

The importance of a multidisciplinary approach to endocrine tumors.

Douglas B. Evans, Tracy S. Wang, 2010, Surgery.

Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.

A. Garden, K. Ang, Douglas B. Evans, 2009, International journal of radiation oncology, biology, physics.

Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

Jeffrey E. Lee, Douglas B. Evans, M. Wallace, 2005, Archives of surgery.

Phase II Study of Docetaxel in Patients with Pancreatic Cancer Previously Untreated with Cytotoxic Chemotherapy

Douglas B. Evans, R. Lenzi, J. Abbruzzese, 2002, Cancer investigation.

Carcinoid tumors of the duodenum.

Jeffrey E. Lee, Douglas B. Evans, Huamin Wang, 2005, Surgery.

Borderline Resectable Adrenal Cortical Carcinoma: A Potential Role for Preoperative Chemotherapy

Jeffrey E. Lee, Douglas B. Evans, C. Wood, 2014, World Journal of Surgery.

Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer

Douglas B. Evans, R. Hwang, Huamin Wang, 2008, Annals of Surgical Oncology.

Combined EUS with FNA and ERCP for the evaluation of patients with obstructive jaundice from presumed pancreatic malignancy.

Douglas B. Evans, R. Wolff, Jeffrey H. Lee, 2008, Gastrointestinal endoscopy.

Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines

L. Ellis, Wenbiao Liu, F. Fan, 2005, Cancer.

Parathyroid Management in the MEN Syndromes

Douglas B. Evans, Tracy S. Wang, 2021 .

The Clinical Utility of Preoperative Thyroglobulin for Surgical Decision Making in Thyroid Disease.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2021, The Journal of surgical research.

Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.

Douglas B. Evans, D. Ayers, T. Breslin, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved

Y. Liu, Douglas B. Evans, J. Findling, 2018, World Journal of Surgery.

Pancreas Adenocarcinoma and Ampullary Cancer

Douglas B. Evans, S. Tsai, K. Christians, 2016 .

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer

B. Erickson, Douglas B. Evans, S. Tsai, 2016 .

Evolution of the Management of Resectable Pancreatic Cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2016, Journal of oncology practice.

Neoadjuvant therapy for localized pancreatic cancer: guiding principles.

B. Erickson, Douglas B. Evans, F. Johnston, 2015, Journal of gastrointestinal oncology.

Neoadjuvant therapy for localized pancreatic cancer: support is growing?

B. Erickson, Douglas B. Evans, P. Ritch, 2015, Annals of surgery.

Neoadjuvant Chemotherapy and Radiochemotherapy: Is There a Survival Advantage for Pancreatic Cancer Patients?

Douglas B. Evans, S. Tsai, K. Christians, 2015 .

Margin Status Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Implications of R Status

Douglas B. Evans, C. Raut, Huamin Wang, 2008 .

Preoperative combined modality therapy for pancreatic cancer

Douglas B. Evans, T. A. Rich, 1995, World Journal of Surgery.

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

Jeffrey E. Lee, K. Hess, Douglas B. Evans, 2001, Annals of Surgical Oncology.

Diagnosis and assessment of resectability for neoplasms of the pancreas and periampullary region

Douglas B. Evans, R. Erickson, 2001 .

Pancreatic Cancer Surgical Practice Guidelines

Douglas B. Evans, J. Jessup, T. Colacchio, 1997 .

Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head*

Jeffrey E. Lee, Douglas B. Evans, J. Abbruzzese, 1996 .

Preoperative chemoradiation for adenocarcinoma of the pancreas: M.D. Anderson experience

Jeffrey E. Lee, Douglas B. Evans, S. Leach, 1995 .

Gastric Cancer Surgical Practice Guidelines

Douglas B. Evans, J. Jessup, T. Colacchio, 1997 .

Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer.

Douglas B. Evans, C. Solórzano, 2007, Surgery.

Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma: Improvements Needed in Population-Based Registries

Douglas B. Evans, T. Gamblin, S. Pappas, 2013, Annals of Surgical Oncology.

Outpatient minimally invasive parathyroidectomy is safe for elderly patients.

Jeffrey E. Lee, Douglas B. Evans, H. Holmes, 2009, Journal of the American College of Surgeons.

Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment.

Jeffrey E. Lee, Douglas B. Evans, E. Mittendorf, 2007, Hematology/oncology clinics of North America.

Advances in Genetics, Diagnosis, Localization, and Treatment

Jeffrey E. Lee, Douglas B. Evans, E. Mittendorf, 2007 .

Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas

Douglas B. Evans, S. Tsai, K. Christians, 2018 .

Neuroendocrine Tumors of the Pancreas

Douglas B. Evans, S. Tsai, K. Christians, 2016 .

Perioperative Management and Outcomes of Hyperthyroid Patients Unable to Tolerate Antithyroid Drugs

Douglas B. Evans, Tracy S. Wang, Dhaval Patel, 2020, World Journal of Surgery.

Overexpression of synuclein‐γ in pancreatic adenocarcinoma

K. Hess, Douglas B. Evans, J. Abbruzzese, 2004 .

Health Care Disparities and the Future of Pancreatic Cancer Care.

Douglas B. Evans, J. Tseng, Marianna V. Papageorge, 2021, Surgical oncology clinics of North America.

Enhanced S taging a nd A ll C hemotherapy P reoperatively i n Patients w ith P otentially R esectable G astric C arcinoma

S. Curley, Douglas B. Evans, J. Ajani, 1999 .

Parathyroid carcinoma: A 22‐year experience

Jeffrey E. Lee, A. Garden, R. Weber, 2004, Head & neck.

DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.

Manal M. Hassan, H. Friess, Douglas B. Evans, 2002, Mutation research.

Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis

Douglas B. Evans, O. Basturk, S. Maithel, 2021, Modern Pathology.

Fine‐needle aspiration cytology of mucinous tumors of the pancreas

Douglas B. Evans, S. Krishnamurthy, M. Recine, 2004, Cancer.

Pancreaticoduodenectomy and Vascular Resection: Persistent Controversy and Current Recommendations

Douglas B. Evans, K. Christians, 2009, Annals of Surgical Oncology.

Wide Variability in Catecholamine Levels From Adrenal Venous Sampling in Primary Aldosteronism.

Douglas B. Evans, S. Kidambi, J. Findling, 2022, The Journal of surgical research.

Arterial variants in pancreatic adenocarcinoma

Douglas B. Evans, S. Faria, C. Charnsangavej, 2008, Abdominal Imaging.

Abdominal Visceral Lesions in von Hippel-Lindau Disease: Incidence and Clinical Behavior of Pancreatic and Adrenal Lesions at a Single Center

Jeffrey E. Lee, S. Curley, Douglas B. Evans, 2006, World Journal of Surgery.

Small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors: Observation becoming standard of care?

Douglas B. Evans, C. Clarke, 2019, Surgery.

Needlestick Occurrences and Reporting Among Residents in the Operative Setting.

Douglas B. Evans, Neal Sethi, Amy Murray, 2020, Journal of surgical education.

A Novel Reconstruction Technique During Pancreaticoduodenectomy After Roux-En-Y Gastric Bypass: How I do It

Douglas B. Evans, S. Tsai, K. Christians, 2017, Journal of Gastrointestinal Surgery.

Postoperative radiotherapy for advanced medullary thyroid cancer—Local disease control in the modern era

A. Garden, Douglas B. Evans, G. Clayman, 2008, Head & neck.

Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach.

Douglas B. Evans, R. Hwang, Huamin Wang, 2008, Journal of the American College of Surgeons.

Epidermal Growth Factor Receptor Blockade with C 225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms 1

Douglas B. Evans, D. Hicklin, D. McConkey, 2000 .

Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.

Douglas B. Evans, G. Cote, M. Habra, 2004, The Journal of clinical endocrinology and metabolism.

Low 24-hour urine calcium levels in patients with sporadic primary hyperparathyroidism: is further evaluation warranted prior to parathyroidectomy?

Douglas B. Evans, Tracy S. Wang, T. Yen, 2015, American journal of surgery.

Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2006, Carcinogenesis.

Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells

Douglas B. Evans, M. Frazier, J. Abbruzzese, 1996, International journal of pancreatology : official journal of the International Association of Pancreatology.

Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy

A. Garden, Douglas B. Evans, G. Clayman, 2009, Head & neck.

Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)

Douglas B. Evans, D. Winchester, D. Winchester, 2015, Annals of Surgical Oncology.

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

Jeffrey E. Lee, Douglas B. Evans, G. Ayers, 2003, Archives of surgery.

Neoplasms of the Exocrine Pancreas

Douglas B. Evans, R. Wolff, J. Abbruzzese, 2003 .

Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence

Yuhree Kim, J. Sicklick, T. Pawlik, 2015, Annals of Surgical Oncology.

Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes

Yuhree Kim, J. Sicklick, T. Pawlik, 2015, Annals of Surgical Oncology.

Adrenal cortical carcinoma

Jeffrey E. Lee, Douglas B. Evans, A. Dackiw, 2001, World Journal of Surgery.

The Nuclear Factor-kB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

Douglas B. Evans, J. Abbruzzese, K. Cleary, 1998 .

A postoperative parathyroid hormone‐based algorithm to reduce symptomatic hypocalcemia following completion/total thyroidectomy: A retrospective analysis of 591 patients

Douglas B. Evans, Y. Liu, Tracy S. Wang, 2018, Surgery.

Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?

Jeffrey E. Lee, Douglas B. Evans, N. Perrier, 2008, Surgery.

Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression‐free survival among patients with low‐grade neuroendocrine tumors

Douglas B. Evans, J. Vauthey, A. Rashid, 2007, Cancer.

Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer

B. Erickson, Douglas B. Evans, E. A. Asare, 2016, Journal of surgical oncology.

Treatment options for metastatic neuroendocrine tumors.

Douglas B. Evans, James C Yao, A. Phan, 2008, Surgery.

Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important.

Jeffrey E. Lee, Douglas B. Evans, Huamin Wang, 2011, Surgery.

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

Jeffrey E. Lee, Douglas B. Evans, A. Maitra, 2016, Journal of Gastrointestinal Surgery.

Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adjuvant Therapy for Pancreatic Cancer: A Logical Strategy in Search of Progress

Douglas B. Evans, R. Wolff, 2011, Annals of Surgical Oncology.

Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery.

Jeffrey E. Lee, Douglas B. Evans, M. Kouvaraki, 2006, Surgery.

bcl-2 and p 53 Expression in Resectable Pancreatic Adenocarcinomas : Association with Clinical Outcome 1

Douglas B. Evans, S. Leach, J. Lee, 2005 .

Surgical Management of Parathyroid and Adrenal Glands in Inherited Medullary Thyroid Carcinoma

Douglas B. Evans, Azadeh A. Carr, 2016 .

Neoadjuvant therapy for pancreatic cancer in patients older than age 75.

B. Erickson, Douglas B. Evans, F. Johnston, 2014 .

Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma

B. Erickson, Douglas B. Evans, S. Tsai, 2019, Annals of Surgical Oncology.

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2010, Annals of Surgical Oncology.

COMMENTARY: Preoperative Chemoradiation Therapy for Pancreatic Cancer

Douglas B. Evans, P. Pisters, 2001 .

Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation.

Douglas B. Evans, W. Chan, R. Wolff, 2007, Journal of pain and symptom management.

Effects of base excision repair gene polymorphisms on pancreatic cancer survival

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2007, International journal of cancer.

Adenocarcinoma of the pancreas

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 1996 .

– PANCREATIC TUMORS Neoadjuvant Chemotherapy for Localized Pancreatic Cancer : Too Little or Too Long ?

Douglas B. Evans, R. White, Rebekah R. White, 2014 .

Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma.

B. Erickson, Douglas B. Evans, P. Parikh, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane

Jeffrey E. Lee, Douglas B. Evans, G. Callender, 2009, Annals of Surgical Oncology.

Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma.

Jeffrey E. Lee, Douglas B. Evans, C. Ng, 2007, Surgery.

Population based study of islet cell carcinoma

Douglas B. Evans, M. Eisner, James C Yao, 2007 .

Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy.

Douglas B. Evans, K. Christians, R. Kim, 2020, Hepatobiliary surgery and nutrition.

Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2012, Cancer.

Anatomy of the Superior Mesenteric Vein With Special Reference to the Surgical Management of First-order Branch Involvement at Pancreaticoduodenectomy

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 2008, Annals of surgery.

Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument.

Douglas B. Evans, R. Groeschl, T. Gamblin, 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2017, The Journal of surgical research.

Intraoperative ex vivo parathyroid aspiration: A point-of-care test to confirm parathyroid tissue.

Douglas B. Evans, Kathryn E. Coan, Tracy S. Wang, 2016, Surgery.

Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer

Douglas B. Evans, S. Faria, C. Charnsangavej, 2007 .

IORT in Pancreatic Carcinoma

Douglas B. Evans, C. Willett, P. Termuhlen, 1999 .

NF-kappaB in pancreatic cancer.

Douglas B. Evans, P. Chiao, C. Schmidt, 2003, International journal of gastrointestinal cancer.

h Levels of Expression of Human Stromal Cell–Derived tor-1 Are Associated with Worse Prognosis in Patients

Douglas B. Evans, Huamin Wang, D. Zander, 2010 .

Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer.

Douglas B. Evans, S. Tsai, K. Christians, 2016, The Surgical clinics of North America.

Venous Shunting Procedures for Borderline Resectable Pancreatic Cancer

Jeffrey E. Lee, Douglas B. Evans, S. Tsai, 2016 .

Venous resection in pancreatic cancer surgery.

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 2006, Best practice & research. Clinical gastroenterology.

Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.

Douglas B. Evans, J. Findling, Tracy S. Wang, 2016, Surgery.

Hereditary Syndromes Involving Pheochromocytoma and Paraganglioma

Douglas B. Evans, Jennifer L. Geurts, Tracy S. Wang, 2016 .

Hereditary Pheochromocytoma and Multiple Endocrine Neoplasia Type 2 (MEN2)

Douglas B. Evans, T. Rich, C. Jimenez, 2010 .

Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2011, Annals of Surgical Oncology.

Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation.

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2003, Molecules and Cells.

Long-term outcomes of surgical treatment for hereditary pheochromocytoma.

Jeffrey E. Lee, Douglas B. Evans, C. Ng, 2013, Journal of the American College of Surgeons.

Intraoperative Radiation Therapy Following Pancreaticoduodenectomy

F. Ames, Douglas B. Evans, D. Byrd, 1993, Annals of surgery.

Function of Nuclear Factor (cid:1) B in Pancreatic Cancer Metastasis 1

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2003 .

The Added Value of Multidisciplinary Care for Patients with Pancreatic Cancer

Douglas B. Evans, C. Charnsangavej, R. Wolff, 2008, Annals of Surgical Oncology.

Utility of Epinephrine Levels in Determining Adrenal Vein Cannulation during Adrenal Venous Sampling for Primary Aldosteronism.

Douglas B. Evans, S. Kidambi, J. Findling, 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Management of suspected adrenal metastases at 2 academic medical centers.

Douglas B. Evans, C. Solórzano, Tracy S. Wang, 2016, American journal of surgery.

Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.

Jeffrey E. Lee, Douglas B. Evans, R. Gonzalez, 2005, Surgery.

Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening

Douglas B. Evans, C. Warneke, N. Perrier, 2012, Annals of Surgical Oncology.

Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?

Jeffrey E. Lee, Douglas B. Evans, Y. Xing, 2010, Surgery.

Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?

Jeffrey E. Lee, Douglas B. Evans, N. Perrier, 2007, Annals of Surgical Oncology.

Invited commentary: medullary thyroid cancer: the importance of RET testing.

Douglas B. Evans, G. Cote, S. Shapiro, 2007, Surgery.

Surgical management of hereditary pheochromocytoma.

Jeffrey E. Lee, Douglas B. Evans, L. Yip, 2004, Journal of the American College of Surgeons.

Neoadjuvant Treatment in Pancreatic Cancer

Douglas B. Evans, Alysandra Lal, 2010 .

Selective Glucocorticoid Replacement Following Unilateral Adrenalectomy for Hypercortisolism and Primary Aldosteronism.

Douglas B. Evans, J. Findling, Tracy S. Wang, 2021, The Journal of clinical endocrinology and metabolism.

Chapter 9:Metakaryotic Cancer Stem Cells are Constitutively Resistant to X-Rays and Chemotherapeutic Agents, but Sensitive to Many Common Drugs

W. Thilly, Douglas B. Evans, D. Chung, 2016 .

Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy.

Douglas B. Evans, 2020, Surgery.

Distal splenorenal and mesocaval shunting at the time of pancreatectomy

B. Erickson, Douglas B. Evans, S. Tsai, 2018, Surgery.

Local control in resectable and borderline resectable pancreatic cancer (PCa) treated with preoperative chemoradiation using IMRT or chemotherapy alone.

B. Erickson, Douglas B. Evans, S. Tsai, 2013 .

Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2003, Oncogene.

Thyroid Cancer: 1999 Update and Evaluation of Solitary Thyroid Nodules

Douglas B. Evans, D. Tyler, J. Moley, 2000, Annals of Surgical Oncology.

Nonlocalizing imaging studies for hyperparathyroidism: where to explore first?

Douglas B. Evans, F. Quiroz, Tracy S. Wang, 2011, Journal of the American College of Surgeons.

Suppression of Tumorigenesis and Induction of p 15 ink 4 b by Smad 4 / DPC 4 in Human Pancreatic Cancer Cells 1

Douglas B. Evans, D. Ayers, T. Breslin, 2002 .

Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy

B. Erickson, Douglas B. Evans, P. Ritch, 2010, Annals of Surgical Oncology.

Cavernous Transformation of the Portal Vein Requiring Temporary Mesocaval Shunt and Internal Jugular Vein Interposition Graft

Douglas B. Evans, K. Christians, George Younan, 2017 .

Pancreaticoduodenectomy and Vascular Reconstruction: Indications and Techniques.

Douglas B. Evans, K. Christians, 2021, Surgical oncology clinics of North America.

Goals of Treatment Sequencing for Localized Pancreatic Cancer

Douglas B. Evans, S. Tsai, M. Kamgar, 2019, Annals of Surgical Oncology.

Distal splenorenal and temporary mesocaval shunting at the time of pancreatectomy for cancer: initial experience from the Medical College of Wisconsin.

B. Erickson, Douglas B. Evans, S. Pappas, 2013, Surgery.

Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy.

Douglas B. Evans, A. Singhi, N. Bahary, 2022, JAMA surgery.

Multiple Endocrine Neoplasia Syndromes

Douglas B. Evans, H. Goepfert, R. Gagel, 2002 .

Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2022, JAMA surgery.

Tyrosine kinase receptor RON in human pancreatic cancer

L. Ellis, F. Fan, Douglas B. Evans, 2007, Cancer.

ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas.

K. Hess, Douglas B. Evans, P. Pisters, 2002, Annals of surgery.

Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.

Jeffrey E. Lee, T. Pawlik, Douglas B. Evans, 2005, Archives of surgery.

Additional Support for Neoadjuvant Therapy in the Management of Pancreatic Cancer

Douglas B. Evans, K. Christians, 2015, Annals of Surgical Oncology.

Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB.

Douglas B. Evans, Wei Zhang, J. Abbruzzese, 2004, Journal of Biological Chemistry.

Portal vein resection.

Douglas B. Evans, S. Pappas, K. Christians, 2010, The Surgical clinics of North America.

Control of Bleeding from the Portal/Superior Mesenteric Vein

Douglas B. Evans, S. Shankar, J. Tseng, 2007 .

Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism.

Jeffrey E. Lee, Douglas B. Evans, E. Jackson, 2009, Surgery.

Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2003, Oncogene.

Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence

Douglas B. Evans, J. Rosen, C. Solórzano, 2018, Annals of Surgical Oncology.

High Levels of Expression of Human Stromal Cell–Derived Factor-1 Are Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

Douglas B. Evans, Huamin Wang, D. Zander, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Parathyroidectomy Improves Functional Capacity in “Asymptomatic” Older Patients With Primary Hyperparathyroidism: A Randomized Control Trial

Jeffrey E. Lee, Douglas B. Evans, G. Morris, 2010, Annals of surgery.

Primary hyperparathyroidism with a history of head and neck irradiation: the consequences of associated thyroid tumors.

Douglas B. Evans, Tracy S. Wang, Douglas B Evans, 2011, Surgery.

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

L. Ellis, Wenbiao Liu, F. Fan, 2005, Cancer research.

Recent advances in thyroid cancer.

R. Weber, B. Fornage, Douglas B. Evans, 2008, Current problems in surgery.

Variant anatomy of the biliary system as a cause of pancreatic and peri-ampullary cancers.

Douglas B. Evans, S. Maithel, P. Mittal, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models

Douglas B. Evans, J. Gershan, S. Tsai, 2018, BMC Cancer.

Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.

H. Friess, Douglas B. Evans, S. Sen, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

K-ras Mutation and p16 and Preproenkephalin Promoter Hypermethylation in Plasma DNA of Pancreatic Cancer Patients: In Relation to Cigarette Smoking

Li Jiao, Manal M. Hassan, Douglas B. Evans, 2007, Pancreas.

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Douglas B. Evans, N. Lee, M. Santoro, 2015, Thyroid : official journal of the American Thyroid Association.

Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians

Douglas B. Evans, S. Sen, C. Amos, 2007, Clinical Cancer Research.

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma

Douglas B. Evans, Huamin Wang, S. Kopetz, 2011, PloS one.

Levels of Expression of Human Stromal Cell – Derived tor-1 Are Associated with Worse Prognosis in Patients B & P Stage II Pancreatic Ductal Adenocarcinoma

Douglas B. Evans, Huamin Wang, D. Zander, 2010 .

Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

Stanley R Hamilton, Douglas B. Evans, A. Rashid, 2008, Clinical Cancer Research.

Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.

Douglas B. Evans, B. Volkman, A. Getschman, 2015, Cancer research.

NF-κB in pancreatic cancer

Douglas B. Evans, P. Chiao, C. Schmidt, 2003 .

Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA

Douglas B. Evans, D. Tuveson, Y. Liu, 2020, Clinical Cancer Research.

Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA

Douglas B. Evans, D. Tuveson, Y. Liu, 2020, Clinical Cancer Research.

Function of Nuclear Factor κB in Pancreatic Cancer Metastasis

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2003 .

XRCC2 and XRCC3 Gene Polymorphismand Risk of Pancreatic Cancer

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2008, The American Journal of Gastroenterology.

XRCC 2 and XRCC 3 Gene Polymorphism and Risk of Pancreatic Cancer

Douglas B. Evans, R. Wolff, M. Hassan, 2008 .

Selected polymorphisms of DNA repair genes and risk of pancreatic cancer.

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2006, Cancer detection and prevention.

Regulatory role of c-Met in insulin-like growth factor-I receptor–mediated migration and invasion of human pancreatic carcinoma cells

Lee M Ellis, L. Ellis, Wenbiao Liu, 2006, Molecular Cancer Therapeutics.

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

Douglas B. Evans, R. Wolff, G. Varadhachary, 2007, Cancer.

Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level

Michael T. Zimmermann, Douglas B. Evans, M. Zimmermann, 2021, Frontiers in Oncology.

High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

Douglas B. Evans, A. Rashid, Huamin Wang, 2010, Clinical Cancer Research.

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma

Douglas B. Evans, A. Rashid, Huamin Wang, 2011, Cancer.

Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases.

Douglas B. Evans, E. Abdalla, S. Kopetz, 2008, Clinical colorectal cancer.

Association between body mass index and multigland primary hyperparathyroidism.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2016, The Journal of surgical research.

Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost?

Jeffrey E. Lee, Douglas B. Evans, S. Cantor, 2012, Journal of the American College of Surgeons.

Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography.

Jeffrey E. Lee, B. Edeiken, Douglas B. Evans, 2006, Surgery.

Confirmation of Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques?

Douglas B. Evans, Kathryn E. Coan, Tracy S. Wang, 2020, The Journal of surgical research.

Medullary thyroid cancer: management guidelines of the American Thyroid Association.

H. Gharib, Douglas B. Evans, R. Kloos, 2009, Thyroid : official journal of the American Thyroid Association.

Adjuvant Therapy for Adenocarcinoma of the Pancreas: Analysis of Reported Trials and Recommendations for Future Progress

Douglas B. Evans, R. Wolff, G. Varadhachary, 2008, Annals of Surgical Oncology.

Current diagnosis and management of unusual pancreatic tumors.

Douglas B. Evans, Huamin Wang, M. Katz, 2008, American journal of surgery.

The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

Douglas B. Evans, J. Abbruzzese, K. Cleary, 1999 .

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.

Douglas B. Evans, J. Ajani, James C Yao, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant therapy for resectable pancreatic cancer.

Douglas B. Evans, C. Raut, R. Wolff, 2004, Surgical oncology clinics of North America.

Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

Douglas B. Evans, Huamin Wang, J. Fleming, 2009, Nature Protocols.

Human cell line from an adenocarcinoma of the ampulla of vater

Douglas B. Evans, B. Levin, D. Byrd, 1992, In Vitro Cellular & Developmental Biology - Animal.

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008, Journal of the American College of Surgeons.

Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

Jeffrey E. Lee, Douglas B. Evans, Huamin Wang, 2006, Annals of Surgical Oncology.

Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer

B. Erickson, Douglas B. Evans, M. Riese, 2020, Frontiers in Oncology.

Total Neoadjuvant Therapy for Operable Pancreatic Cancer

B. Erickson, Douglas B. Evans, S. Tsai, 2020, Annals of Surgical Oncology.

Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer

Douglas B. Evans, L. Santarpia, S. Sherman, 2009, Head & neck.

Cell cycle regulation of human pancreatic cancer by tamoxifen

Douglas B. Evans, J. Abbruzzese, P. Chiao, 1998, Annals of Surgical Oncology.

Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2003, Journal of Gastrointestinal Surgery.

Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.

Jeffrey S. Morris, Jeffrey E. Lee, Douglas B. Evans, 2009, Archives of surgery.

Postpancreatectomy Hemorrhage: Early and Late

Douglas B. Evans, A. Amini, K. Christians, 2015 .

Acute pancreatitis with normal amylase

Douglas B. Evans, Andrew Robinson, R. J. Pettit, 1986, Digestive Diseases and Sciences.

Posterior retroperitoneoscopic adrenalectomy.

Jeffrey E. Lee, Douglas B. Evans, G. Callender, 2009, Advances in surgery.

Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2012, Surgery.

Mechanisms of synthetic serine protease inhibitor (FUT‐175)‐mediated cell death

Douglas B. Evans, M. Hung, J. Abbruzzese, 2007, Cancer.

Potential role for intraoperative gamma probe identification of normal parathyroid glands.

Jeffrey E. Lee, Douglas B. Evans, S. Sherman, 2003, American journal of surgery.

Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1

Jeffrey E. Lee, Douglas B. Evans, M. Kouvaraki, 2006, World Journal of Surgery.

Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial

D. Sahani, J. Meyerhardt, Douglas B. Evans, 2019, Annals of Surgical Oncology.

Risk Factors for Pancreatic Cancer: Case-Control Study

Manal M. Hassan, Douglas B. Evans, J. Vauthey, 2007, The American Journal of Gastroenterology.

Preventable reoperations for persistent and recurrent papillary thyroid carcinoma.

Jeffrey E. Lee, Douglas B. Evans, M. Kouvaraki, 2004, Surgery.

Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence.

Jeffrey E. Lee, B. Edeiken, Douglas B. Evans, 2009, Surgery.

A single parathyroid hormone level obtained 4 hours after total thyroidectomy predicts the need for postoperative calcium supplementation.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2014, Journal of the American College of Surgeons.

Development of a high risk pancreatic screening clinic using 3.0 T MRI

Douglas B. Evans, S. Tsai, K. Christians, 2017, Familial Cancer.

Precision Medicine for Pancreatic Cancer

Douglas B. Evans, S. Tsai, R. Kim, 2021 .

Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2020, Surgery.

Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma

Saurav Mallik, F. Sonohara, Y. Kodera, 2020, Annals of surgery.

Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?

B. Erickson, Douglas B. Evans, S. Tsai, 2019, Journal of Gastrointestinal Surgery.

Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma

Kathleen A. Boyle, Douglas B. Evans, R. Hwang, 2016, Laboratory Investigation.

Fine‐needle aspiration of pancreatic extramedullary plasmacytoma: Possible confusion with islet cell tumor

Douglas B. Evans, L. Dodd, F. Symmans, 1994, Diagnostic cytopathology.

Enrichment Methods for Mutation Detection

Douglas B. Evans, D. Evans, F. A. Benko, 2000, Annals of the New York Academy of Sciences.

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.

Nancy D Perrier, Jeffrey E. Lee, Douglas B. Evans, 2005, Thyroid : official journal of the American Thyroid Association.

Common Locations of Parathyroid Adenomas

Jeffrey E. Lee, Douglas B. Evans, G. Callender, 2011, Annals of Surgical Oncology.

Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.

Douglas B. Evans, G. Rassidakis, P. Chiao, 2006, Cancer research.

Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

Jeffrey E. Lee, Douglas B. Evans, M. Kouvaraki, 2002, Archives of surgery.

Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.

Jeffrey E. Lee, Douglas B. Evans, E. Sturgis, 2012, Surgery.

Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography.

Jeffrey E. Lee, B. Edeiken, Douglas B. Evans, 2008, Journal of the American College of Surgeons.

Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism.

Jeffrey E. Lee, Douglas B. Evans, E. Mittendorf, 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed.

Douglas B. Evans, A. Szabo, Tracy S. Wang, 2013, JAMA surgery.

Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

Steven, Douglas B. Evans, N. Lee, 2018, Pediatrics.

Delayed Calcium Normalization After Presumed Curative Parathyroidectomy is Not Associated with the Development of Persistent or Recurrent Primary Hyperparathyroidism

Douglas B. Evans, Tracy S. Wang, T. Yen, 2016, Annals of Surgical Oncology.

DGKζ exerts greater control than DGKα over CD8+ T cell activity and tumor inhibition

Douglas B. Evans, M. Riese, H. Desilva, 2021, Oncoimmunology.

NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2004, Molecular and cellular biology.

Current Approaches and Future Strategies for Pancreatic Carcinoma

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2000, Investigational New Drugs.

Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin‐1 by epidermal growth factor in human pancreatic carcinoma

Lee M Ellis, Christiane J Bruns, L. Ellis, 2003, Cancer.

Tumor Suppressor Gene Smad4/DPC4, Its Downstream Target Genes, and Regulation of Cell Cyclea

K. Hunt, Douglas B. Evans, Wei Zhang, 1999 .

Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.

Douglas B. Evans, Huamin Wang, J. Abbruzzese, 2009, Cancer research.

Immunocytochemical study of the expression of mesothelin in fine‐needle aspiration biopsy specimens of pancreatic adenocarcinoma

Douglas B. Evans, S. Krishnamurthy, R. Hwang, 2007, Diagnostic cytopathology.

Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: A case‐control study

Manal M. Hassan, Douglas B. Evans, J. Vauthey, 2008, Cancer.

Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Philip R. O. Payne, Steven M. Johnson, David A. Eichmann, 2022, Annals of Surgical Oncology.

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Sunil Krishnan, Jeffrey E. Lee, Douglas B. Evans, 2009, Annals of Surgical Oncology.

BORDERLINE RESECTABLE PANCREATIC CANCER

Douglas B. Evans, R. Wolff, G. Varadhachary, 2014 .

Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.

Douglas B. Evans, R. Wolff, P. Pisters, 2008, International journal of radiation oncology, biology, physics.

Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer

Douglas B. Evans, S. Faria, C. Charnsangavej, 2007, Abdominal Imaging.

Pre-operative ultrasound identification of thyroiditis helps predict the need for thyroid hormone replacement after thyroid lobectomy.

Jeffrey E. Lee, Douglas B. Evans, C. Warneke, 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma

Douglas B. Evans, S. Tsai, K. Christians, 2013, Journal of surgical oncology.

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2015, Annals of Surgical Oncology.

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adrenal oncocytic pheochromocytoma with functionality in a neurofibromatosis patient: A case report

K. Iczkowski, Douglas B. Evans, S. Suster, 2018, Human Pathology: Case Reports.

The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis

Douglas B. Evans, T. McDonnell, M. Tsao, 2002, Oncogene.

Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma.

Jeffrey E. Lee, Douglas B. Evans, N. Perrier, 2011, Surgery.

5,10-Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Pancreatic Cancer

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2005, Cancer Epidemiology Biomarkers & Prevention.

Mechanisms of Proinflammatory Cytokine-Induced Biphasic NF-κB Activation.

Douglas B. Evans, J. Abbruzzese, P. Chiao, 2003 .

Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Douglas B. Evans, M. Dwinell, Ishan Roy, 2014, Surgery.

Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.

Yuhree Kim, J. Sicklick, T. Pawlik, 2016, JAMA surgery.

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.

Douglas B. Evans, T. McDonnell, M. Tsao, 2002, Oncogene.

Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.

K. Hess, Douglas B. Evans, Huamin Wang, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-Nucleotide Polymorphisms of DNA Damage Response Genes Are Associated with Overall Survival in Patients with Pancreatic Cancer

Douglas B. Evans, Donghui Li, J. Abbruzzese, 2008, Clinical Cancer Research.

Single Nucleotide Polymorphisms of RecQ 1 , RAD 54 L and ATM Genes Are Associated With Reduced Survival of Pancreatic Cancer

K. Hess, Douglas B. Evans, Donghui Li, 2008 .

Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.

K. Hess, Douglas B. Evans, Donghui Li, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma.

Jeffrey E. Lee, Douglas B. Evans, N. Perrier, 2011, Surgery.

Posterior Retroperitoneoscopic Adrenalectomy: Preferred Technique for Removal of Benign Tumors and Isolated Metastases

Jeffrey E. Lee, Douglas B. Evans, N. Perrier, 2008, Annals of surgery.

Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience.

Jeffrey E. Lee, Douglas B. Evans, C. Ng, 2011, Journal of the American College of Surgeons.

Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.

Bruno D Fornage, Jeffrey E. Lee, B. Fornage, 2003, Surgery.

Effect of Preoperative Biliary Decompression on Pancreaticoduodenectomy-Associated Morbidity in 300 Consecutive Patients

Jeffrey E. Lee, K. Hess, Douglas B. Evans, 2001, Annals of surgery.

Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2007, Journal of the American College of Surgeons.

Underdiagnosis of primary hyperparathyroidism in patients with osteoarthritis undergoing arthroplasty

Douglas B. Evans, Tracy S. Wang, T. Yen, 2021, Surgery.

Parathyroidectomy for primary hyperparathyroidism improves sleep quality: A prospective study

Douglas B. Evans, Tracy S. Wang, T. Yen, 2017, Surgery.

An Institutional experience with primary hyperparathyroidism in the elderly over two decades.

Douglas B. Evans, Tracy S. Wang, T. Yen, 2021, American journal of surgery.

Endoscopic Ultrasound in the Diagnosis and Staging of Pancreatic Cancer

Douglas B. Evans, 2017 .

Surgical treatment of non‐functioning pancreatic islet cell tumors

Jeffrey E. Lee, Douglas B. Evans, M. Kouvaraki, 2005, Journal of surgical oncology.

Combined-modality treatment for operable pancreatic adenocarcinoma.

Douglas B. Evans, R. Wolff, P. Pisters, 2005, Oncology.

How I do it: Alternative method for exposure of the retropancreatic mesenteric vasculature during total pancreatectomy

F. Ames, Douglas B. Evans, S. Leach, 1996, Journal of surgical oncology.

On "Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients".

Douglas B. Evans, N. Perrier, 2006, Surgery.

Mesocaval shunting: a novel technique to facilitate venous resection and reconstruction and enhance exposure of the superior mesenteric and celiac arteries during pancreaticoduodenectomy.

Douglas B. Evans, S. Tsai, K. Christians, 2013, Journal of the American College of Surgeons.

Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy.

Douglas B. Evans, 2006, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Intraductal Papillary Mucinous Neoplasms of the Pancreas: Effect of Invasion and Pancreatic Margin Status on Recurrence and Survival

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2006, Annals of Surgical Oncology.

Preoperative chemoradiation for pancreatic cancer.

Douglas B. Evans, 2005, Seminars in oncology.

Letters to the editor [10]

Douglas B. Evans, H. Hashimi, D. S. Tyler, 1995 .

Reoperative Pancreaticoduodenectomy

Douglas B. Evans, D. Tyler, 1994, Annals of surgery.

The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma

Jeffrey E. Lee, Douglas B. Evans, D. Bentrem, 2013, Annals of Surgical Oncology.

Premonitory symptoms preceding metastatic medullary thyroid cancer in multiple endocrine neoplasia type 2B: An exploratory analysis

Douglas B. Evans, S. Waguespack, T. Rich, 2008 .

Surgical management of thyroid carcinoma.

Jeffrey E. Lee, Douglas B. Evans, M. Kouvaraki, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.

Jeffrey E. Lee, Douglas B. Evans, S. Sherman, 2003, Surgery.

Surgical Management of Familial Hyperparathyroidism

Douglas B. Evans, G. Cote, T. Rich, 2007, Annals of Surgical Oncology.

Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.

B. Erickson, Douglas B. Evans, S. Tsai, 2019, Surgery.

Induction Ofp 2 Jwaf . l Expression and Growth Inhibition by Transforming Growth Factor 1 @ Involve the Tumor Suppressor Gene DPC 4 in Human Pancreatic Adenocarcinoma Cells

Douglas B. Evans, Wei Zhang, J. Abbruzzese, 2006 .

Pancreatic malignancy involving the superior mesenteric-portal vein confluence is not a contraindication to pancreaticoduodenectomy

S. Curley, Douglas B. Evans, S. Leach, 1995 .

CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer

B. Erickson, Douglas B. Evans, S. Tsai, 2023, Annals of Surgical Oncology.

Rational Study Endpoint(s) for Preoperative Trials in Pancreatic Cancer: Pathologic Response Rate, Margin Negative Resection, Overall Survival or ‘All of the Above’?

Douglas B. Evans, G. Varadhachary, 2013, Annals of Surgical Oncology.

Vascular Reconstruction During the Whipple Operation

Douglas B. Evans, K. Christians, Alysandra Lal, 2011 .

Management of borderline resectable pancreatic cancer.

Douglas B. Evans, K. Christians, Alysandra Lal, 2010, Surgical oncology clinics of North America.

Comment and perspective on Sewnath and colleagues' recent meta-analysis of the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2003, Annals of surgery.

Screening guidelines and recommendations for patients at high risk of developing endocrine cancers

Douglas B. Evans, Jennifer L. Geurts, Tracy S. Wang, 2020, Journal of surgical oncology.

Population-Based Study of Islet Cell Carcinoma

Douglas B. Evans, M. Eisner, A. Rashid, 2007, Annals of Surgical Oncology.

Defining the Role of Adjuvant External Beam Radiotherapy on Resected Adenocarcinoma of the Ampulla of Vater

B. Erickson, Douglas B. Evans, A. Amini, 2014, Journal of Gastrointestinal Surgery.

No need to abandon unilateral parathyroid surgery.

Douglas B. Evans, Herb Chen, Q. Duh, 2012, Journal of the American College of Surgeons.

Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system.

Jeffrey E. Lee, Douglas B. Evans, E. Silberfein, 2010, Archives of surgery.

Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival

Yuhree Kim, J. Sicklick, T. Pawlik, 2016, World Journal of Surgery.

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

Douglas B. Evans, R. Wolff, G. Varadhachary, 2006, Cancer.

Variation in parathyroid adenoma size in patients with sporadic, primary hyperparathyroidism: small gland size does not preclude single gland disease

Douglas B. Evans, Tracy S. Wang, T. Yen, 2022, Langenbeck's Archives of Surgery.

Optimal Management of the Splenic Vein at the Time of Venous Resection for Pancreatic Cancer: Importance of the Inferior Mesenteric Vein

Douglas B. Evans, S. Tsai, K. Christians, 2014, Journal of Gastrointestinal Surgery.

The Effect of Thyroiditis on the Yield of Central Compartment Lymph Nodes in Patients with Papillary Thyroid Cancer

Douglas B. Evans, Tracy S. Wang, T. Yen, 2015, Annals of Surgical Oncology.

Clinical Significance of Distinguishing Between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-Needle Aspiration Biopsy

Douglas B. Evans, G. Clayman, N. Perrier, 2009, Annals of Surgical Oncology.

Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.

William D Middleton, P Reed Larsen, Mary C Frates, 2006, Radiology.

Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.

Douglas B. Evans, J. Findling, Tracy S. Wang, 2016, Surgery.

Viability of Cryopreserved Parathyroid Tissue: When Is Continued Storage versus Disposal Indicated?

Jeffrey E. Lee, Douglas B. Evans, M. Guerrero, 2008, World Journal of Surgery.

Expression of MAP 4 K 4 Is Associated withWorse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

Douglas B. Evans, A. Rashid, R. Hwang, 2008 .

Factors That Influence Parathyroid Hormone Half-life: Are New Intraoperative Criteria Needed?

Douglas B. Evans, A. Szabo, Tracy S. Wang, 2012 .

The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.

Manal M. Hassan, Douglas B. Evans, M. Hassan, 2007, Cancer letters.

Polymorphisms of p16, p27, p73, and MDM2 Modulate Response and Survival of Pancreatic Cancer Patients Treated with Preoperative Chemoradiation

Douglas B. Evans, S. Sen, C. Amos, 2009, Annals of Surgical Oncology.

Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer.

Douglas B. Evans, S. Sen, C. Amos, 2008, Cancer letters.

Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin

K. Hess, Douglas B. Evans, J. Abbruzzese, 2005, Cancer.

Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2006, Cancer research.

TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation.

Douglas B. Evans, J. Fleming, P. Chiao, 2009, Cancer research.

Secreted Interleukin-1α Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor-κB

Douglas B. Evans, D. Melisi, P. Chiao, 2009, Molecular Cancer Research.

Glutathione S‐transferase gene polymorphisms and risk and survival of pancreatic cancer

Manal M. Hassan, Douglas B. Evans, M. Hassan, 2007, Cancer.

The role of genetics in the surgical management of familial endocrinopathy syndromes.

Jeffrey E. Lee, Douglas B. Evans, R. Gagel, 2003, Journal of the American College of Surgeons.

Pancreatic Cystic Neoplasm: The Role of Cyst Morphology, Cyst Fluid Analysis, and Expectant Management

Douglas B. Evans, J. Fleming, Jeffrey H. Lee, 2009, Annals of Surgical Oncology.

Cancer Antigens 19-9 and 125 in the Differential Diagnosis of Pancreatic Mass Lesions—Invited Critique

Douglas B. Evans, R. Hwang, 2006 .

Single-Nucleotide Polymorphisms of DNADamage Response Genes AreAssociated with Overall Survival in Patients with Pancreatic Cancer

Li-jiao, Douglas B. Evans, Donghui Li, 2008 .

An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: A multicenter cohort study.

Joon-Oh Park, S. Yamada, Y. Kodera, 2022, Gastroenterology.

Asn and Lys 751 Gln polymorphisms , corresponding haplotype , and pancreatic cancer risk

Manal M. Hassan, Douglas B. Evans, M. Hassan, 2008 .

Is previous same quadrant surgery a contraindication to laparoscopic adrenalectomy?

Douglas B. Evans, Herb Chen, A. B. Froyshteter, 2012, Surgery.

Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations

Yingyong Hou, Douglas B. Evans, K. Pacak, 2018, Endocrine.

Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions

Douglas B. Evans, N. Guda, S. Bhandari, 2018, PloS one.

Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods.

B. Erickson, Douglas B. Evans, S. Tsai, 2020, American journal of surgery.

Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.

B. Erickson, Douglas B. Evans, S. Tsai, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers

Douglas B. Evans, S. Meltzer, D. V. Von Hoff, 2021, Clinical Cancer Research.

CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis

Douglas B. Evans, S. Tsai, A. Mackinnon, 2014, PloS one.

The learning curve in pancreatic surgery.

Jeffrey E. Lee, Douglas B. Evans, Huamin Wang, 2007, Surgery.

Tips for authors of surgical manuscripts from senior reviewers.

R. Rege, Douglas B. Evans, A. Harken, 2021, Surgery.

The fallen one: the inferior parathyroid gland that descends into the mediastinum.

Jeffrey E. Lee, Douglas B. Evans, J. Fleming, 2009, Journal of the American College of Surgeons.

Pancreatobiliary Maljunction-associated Gallbladder Cancer Is as Common in the West, Shows Distinct Clinicopathologic Characteristics and Offers an Invaluable Model for Anatomy-induced Reflux-associated Physio-chemical Carcinogenesis

Douglas B. Evans, O. Basturk, W. Jarnagin, 2020, Annals of surgery.

Treatment sequencing for pancreatic neuroendocrine tumors: daring to challenge the status quo.

Douglas B. Evans, C. Clarke, 2020, Journal of Gastrointestinal Oncology.

Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A.

Douglas B. Evans, M. Guerrero, G. Hunter, 2008, Journal of surgical education.

Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication.

Douglas B. Evans, V. Adsay, M. Erkan, 2020, Journal of gastrointestinal oncology.

Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.

Jeffrey E. Lee, L. Ellis, Douglas B. Evans, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst.

Douglas B. Evans, A. Rashid, Huamin Wang, 2010, Annals of diagnostic pathology.

Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes.

E. Bruera, M. Spitz, Douglas B. Evans, 2009, Journal of pain and symptom management.

Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?

Douglas B. Evans, P. Pisters, 2008, Annals of surgery.

Overexpression of synuclein-gamma in pancreatic adenocarcinoma.

K. Hess, Douglas B. Evans, J. Abbruzzese, 2004, Cancer.

Letter to the editor [1] (multiple letters)

K. Hess, Douglas B. Evans, P. Pisters, 2002 .

A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

Jonathan M. Hernandez, B. Erickson, Douglas B. Evans, 2022, Annals of Surgical Oncology.

Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma

Douglas B. Evans, M. Tobi, Mijin Kim, 2013, Digestive Diseases and Sciences.

Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?

B. Erickson, Douglas B. Evans, T. Gamblin, 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer?

B. Erickson, Douglas B. Evans, S. Tsai, 2017, Practical radiation oncology.

Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice.

Douglas B. Evans, T. Gamblin, K. Christians, 2023, The Journal of surgical research.

Updates on the Management of Pancreatic Cancer.

Douglas B. Evans, S. Tsai, 2021, Surgical oncology clinics of North America.

Effect of Prophylactic Central Compartment Neck Dissection on Serum Thyroglobulin and Recommendations for Adjuvant Radioactive Iodine in Patients with Differentiated Thyroid Cancer

Douglas B. Evans, Tracy S. Wang, T. Yen, 2012, Annals of Surgical Oncology.

Multimodality therapy for adenocarcinoma of the pancreas: The M.D. Anderson experience

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 1997 .

Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head

I. Rosen, Douglas B. Evans, K. Forster, 2001, International journal of gastrointestinal cancer.

Followup of patients with papillary thyroid cancer: in search of the optimal algorithm.

Jeffrey E. Lee, B. Edeiken, Douglas B. Evans, 2007, Journal of the American College of Surgeons.

Multidisciplinary management strategy for incidental cystic lesions of the pancreas.

Jeffrey E. Lee, Douglas B. Evans, P. Bhosale, 2010, Journal of the American College of Surgeons.

Do Practice Patterns Reflect Practice Guidelines?

Douglas B. Evans, T. Yen, 2010, Annals of Surgical Oncology.

Population-level predictors of persistent hyperparathyroidism.

Douglas B. Evans, N. Perrier, 2011, Surgery.

Orthotopic and heterotopic generation of murine pancreatic cancer xenografts

Douglas B. Evans, Huamin Wang, G. Gallick, 2014 .

Polymorphisms of genes involved in gemcitabine metabolism correlate with prognosis in patients receiving neoadjuvant therapy for pancreatic cancer

Douglas B. Evans, R. Wolff, Donghui Li, 2008 .

Overexpression of Oncogenic STK 15 / BTAK / Aurora A Kinase in Human Pancreatic Cancer 1

H. Friess, Douglas B. Evans, S. Sen, 2003 .

Resection for cure of carcinoma of the colon directly invading the duodenum or pancreatic head.

S. Curley, Douglas B. Evans, F. Ames, 1994, Journal of the American College of Surgeons.

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008, Journal of the American College of Surgeons.

Letter to the editors

Douglas B. Evans, Jeffrey H. Lee, Christopher H. Crane, 2019, Journal of Gastrointestinal Surgery.

Jeffrey E. Lee, Douglas B. Evans, C. Charnsangavej, 1998 .

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 1997, Annals of surgery.

Borderline resectable pancreatic cancer

Douglas B. Evans, R. Wolff, G. Varadhachary, 2005, Current treatment options in gastroenterology.

Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism.

Jeffrey E. Lee, Douglas B. Evans, A. Dackiw, 2000, Archives of surgery.

Adenocarcinoma of the pancreas: recent controversies, current management, and future therapies

Jeffrey E. Lee, Douglas B. Evans, P. Pisters, 1996 .

Primary pancreatic lymphoma.

S. Curley, Douglas B. Evans, C. Charnsangavej, 1998, Surgery.

Volume-Outcome in Cancer Surgery: Why has the Data Not Affected Policy Change?

Douglas B. Evans, S. Tsai, 2014, Annals of Surgical Oncology.

Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients.

Jeffrey E. Lee, Douglas B. Evans, J. Ajani, 2001, Surgery.

5-FU/leucovorin, irinotecan, oxaliplatin (FOLFIRINOX) induction followed by chemoXRT in borderline resectable pancreatic cancer.

B. Erickson, Douglas B. Evans, K. Christians, 2012 .

Chemokines and chemokine receptors: update on utility and challenges for the clinician.

Douglas B. Evans, M. Dwinell, Ishan Roy, 2014, Surgery.

Recent advances in thyroid cancer. In brief.

R. Weber, B. Fornage, Douglas B. Evans, 2008, Current problems in surgery.

Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial.

Douglas B. Evans, S. Tsai, W. Hall, 2022, JAMA Oncology.

Commentary

Douglas B. Evans, P. Pisters, 2001 .

Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology.

Douglas B. Evans, 2011, Surgery.

Lessons learned from investigator‐initiated clinical trials for localized pancreatic cancer

Douglas B. Evans, S. Tsai, 2021, Journal of surgical oncology.

Subaquatic laparoscopy for staging of intraabdominal malignancy.

Douglas B. Evans, E. Abdalla, B. Feig, 2003, Journal of the American College of Surgeons.

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Douglas B. Evans, N. Lee, M. Santoro, 2015, Thyroid : official journal of the American Thyroid Association.

Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

Douglas B. Evans, N. Lee, M. Santoro, 2018, Pediatrics.

Commentary on: Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.

Douglas B. Evans, Tracy S. Wang, 2017, Surgery.

Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.

Douglas B. Evans, B. Volkman, B. Kalyanaraman, 2015, Cancer research.

5,10-Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Pancreatic Cancer

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2005, Cancer Epidemiology Biomarkers & Prevention.

Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.

Manal M. Hassan, Douglas B. Evans, R. Wolff, 2006, Carcinogenesis.

Preoperative gemcitabine (gem) and bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008 .

Older Patients With Asymptomatic Primary Hyperparathyroidism: Should Criteria for Surgery Be Expanded?

Douglas B. Evans, Tracy S. Wang, T. Yen, 2023, Journal of the Endocrine Society.

Low 24-hour urine calcium levels in patients with sporadic primary hyperparathyroidism: is further evaluation warranted prior to parathyroidectomy?

Douglas B. Evans, Tracy S. Wang, T. Yen, 2014, American journal of surgery.

Population-Based Study of Islet Cell Carcinoma

Douglas B. Evans, M. Eisner, A. Rashid, 2007, Annals of Surgical Oncology.

High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

Douglas B. Evans, A. Rashid, Huamin Wang, 2010, Clinical Cancer Research.

Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?

B. Erickson, Douglas B. Evans, Huamin Wang, 2014, The oncologist.

Updated survival analysis of preoperative gemcitabine (gem) plus bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma.

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2012 .

Analysis of an institutional protocol for thyroid lobectomy: Utility of routine intraoperative frozen section and expedited (overnight) pathology.

Douglas B. Evans, F. Quiroz, Tracy S. Wang, 2016, Surgery.

Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?

Jeffrey E. Lee, Douglas B. Evans, Y. Xing, 2010, Surgery.

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

Jeffrey E. Lee, Douglas B. Evans, G. Ayers, 2003, Archives of surgery.

Handbook of Advanced Cancer Care: Thyroid and adrenal cancer

Douglas B. Evans, Rae Zyn H. Brana, 2003 .

Neoadjuvant Chemotherapy for Localized Pancreatic Cancer: Too Little or Too Long?

Douglas B. Evans, R. White, 2014, Annals of Surgical Oncology.